Projects per year
Personal profile
Education
- 2002.09-2006.12 Ph.D., Institute of Medical Science, National Defense Medical Center
- 1998.09-2000.08 M.S., Institute of Anatomy and Cell Biology, National Yang-Ming University
Experience
- 2019.10- Vice Director, Taipei Heart Institute, Taipei Medical University
- 2018.02- Professor, School of Medicine/ Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2015.08-2018.01 Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2011.08-2018.01 Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2007.08-2011.07 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2007.01-2007.07 Postdoctoral Researcher, Taipei Tzu Chi Hospital
Research Interests
- vascular cell biology
- atherosclerosis and vasculopathy
Fingerprint
Dive into the research topics where Feng-Yen Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
牙周致病菌加劇腹主動脈瘤生成的機制與開發標靶治療的可行性研究(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Effects and Underlying Mechanisms of B Type Natriuretic Peptide in Endothelial-Mesenchymal Transition: a Study Regarding to Cardiac Allograft Vasculopathy
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
The Effects of High Mobility Group Box-1 Protein in Human Vascular Smooth Muscle Progenitor Cells in Regard to the Occurrence of Allograft Vasculopathy after Heart Transplantation
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
The Effects of Lipoprotein on Endothelial Progenitor Cells Function and Endothelial-to-Mesenchymal Transition Process
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
The Influence of Porphyromonas gingivalis Groel in Vascular Cells
8/1/14 → 7/31/15
Project: A - Government Institution › b - Ministry of Science and Technology
-
Inhibition of β-catenin signaling attenuates arteriovenous fistula thickening in mice by suppressing myofibroblasts
Liu, C. T., Hsu, S. C., Hsieh, H. L., Chen, C. H., Chen, C. Y., Sue, Y. M., Chen, T. H., Hsu, Y. H., Lin, F. Y., Shih, C. M., Shiu, Y. T. & Huang, P. H., Dec 2022, In: Molecular Medicine. 28, 1, 7.Research output: Contribution to journal › Article › peer-review
Open Access -
An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis
Tsui, P. F., Chern, C. Y., Lien, C. F., Lin, F. Y., Tsai, C. S., Tsai, M. C. & Lin, C. S., Jun 2021, In: Biochemical Pharmacology. 188, 114581.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
A novel relative high-density lipoprotein index to predict the structural changes in high-density lipoprotein and its ability to inhibit endothelial–mesenchymal transition
Lin, F. Y., Lin, Y. W., Shih, C. M., Lin, S. J., Tung, Y. T., Li, C. Y., Chen, Y. H., Lin, C. Y., Tsai, Y. T. & Huang, C. Y., May 2 2021, In: International journal of molecular sciences. 22, 10, 5210.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Association of multiple preventive therapies postdischarge and long-term health outcomes after acute myocardial infarction
Chen, C. W., Lin, Y. C., Shih, C. M., Chen, W. T., Lin, F. Y., Bi, W. F., Kao, Y. T., Chiang, K. H., Chan, C. S., Hsu, C. Y., Yang, T. L., Hsiao, C. Y., Hsiao, B. Y., Chien, L. N. & Huang, C. Y., Dec 1 2021, In: Journal of the Chinese Medical Association : JCMA. 84, 12, p. 1084-1091 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study
Lin, Y. C., Chen, B. L., Shih, C. M., Lin, F. Y., Chen, C. W., Hsu, C. Y., Kao, Y. T., Bi, W. F., Chen, L. Y., Chien, L. N., Fang, T. C. & Huang, C. Y., Apr 2021, In: PLoS ONE. 16, 4 April, e0249940.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)